Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium Infantis on Lewis lung cancer in mice
Open Access
- 16 September 2011
- journal article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 18 (12), 884-896
- https://doi.org/10.1038/cgt.2011.57
Abstract
Soluble fms-like tyrosine kinase receptor (sFlt-1) is a soluble form of extramembrane part of vascular endothelial growth factor receptor-1 (VEGFR-1) that has antitumor effects. Bifidobacterium Infantis is a kind of non-pathogenic and anaerobic bacteria that may have specific targeting property of hypoxic environment inside of solid tumors. The aim of this study was to construct Bifidobacterium Infantis-mediated sFlt-1 gene transferring system and investigate its antitumor effect on Lewis lung cancer (LLC) in mice. Our results demonstrated that the Bifidobacterium Infantis-mediated sFlt-1 gene transferring system was constructed successfully and the system could express sFlt-1 at the levels of gene and protein. This system could not only significantly inhibit growth of human umbilical vein endothelial cells induced by VEGF in vitro, but also inhibit the tumor growth and prolong survival time of LLC C57BL/6 mice safely. These data suggest that Bifidobacterium Infantis-mediated sFlt-1 gene transferring system presents a promising therapeutic approach for the treatment of cancer.Keywords
This publication has 45 references indexed in Scilit:
- Stereological Evaluation of Laryngeal Cancers Using Computed Tomography Via the Cavalieri MethodThe Journal of Craniofacial Surgery, 2009
- Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in miceBMC Cancer, 2009
- Tumor Cavitation During Therapy with Antiangiogenesis Agents in Patients with Lung CancerJournal of Thoracic Oncology, 2008
- Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hopeJournal of Cellular and Molecular Medicine, 2007
- Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectorsCancer Gene Therapy, 2007
- Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinomaInternational Journal of Gynecologic Cancer, 2006
- Adeno-associated virus vectors: potential applications for cancer gene therapyCancer Gene Therapy, 2005
- Essential Role of Vascular Endothelial Growth Factor and Flt-1 Signals in Neointimal Formation After Periadventitial InjuryArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptorCancer Gene Therapy, 2004
- Antiangiogenesis: The Fifth Cancer Treatment Modality?Oncology Nursing Forum, 2003